Healthcare provider profile · identity verified

Garth A Bennington, MD

Family Practice · NEWARK, OH · NPI 1184606303

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	567	142
Amlodipine Besylate	Amlodipine Besylate	564	147
Losartan Potassium	Losartan Potassium	494	136
Lisinopril	Lisinopril	454	118
Omeprazole	Omeprazole	402	119
Levothyroxine Sodium	Levothyroxine Sodium	401	97
Metoprolol Succinate	Metoprolol Succinate	347	83
Pantoprazole Sodium	Pantoprazole Sodium	269	77
Potassium Chloride	Potassium Chloride	236	58
Glimepiride	Glimepiride	227	61
Gabapentin	Gabapentin	216	53
Rosuvastatin Calcium	Rosuvastatin Calcium	215	59
Hydrochlorothiazide	Hydrochlorothiazide	211	52
Metformin Hcl Er	Metformin Hcl	200	60
Pravastatin Sodium	Pravastatin Sodium	191	55
Jardiance	Empagliflozin	187	39
Metformin Hcl	Metformin Hcl	182	47
Buspirone Hcl	Buspirone Hcl	171	43
Albuterol Sulfate Hfa	Albuterol Sulfate	165	46
Duloxetine Hcl	Duloxetine Hcl	161	37
Eliquis	Apixaban	156	31
Simvastatin	Simvastatin	155	42
Furosemide	Furosemide	145	41
Trazodone Hcl	Trazodone Hcl	143	45
Alendronate Sodium	Alendronate Sodium	135	41
Ozempic	Semaglutide	131	23
Tamsulosin Hcl	Tamsulosin Hcl	129	28
Allopurinol	Allopurinol	127	36
Pioglitazone Hcl	Pioglitazone Hcl	127	36
Escitalopram Oxalate	Escitalopram Oxalate	119	34
Sertraline Hcl	Sertraline Hcl	119	34
Fluticasone Propionate	Fluticasone Propionate	118	38
Metoprolol Tartrate	Metoprolol Tartrate	112	33
Carvedilol	Carvedilol	109	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	25
Meloxicam	Meloxicam	101	28
Lovastatin	Lovastatin	100	27
Cephalexin	Cephalexin	96	68
Famotidine	Famotidine	94	30
Methylprednisolone	Methylprednisolone	93	78
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	27
Montelukast Sodium	Montelukast Sodium	90	24
Prednisone	Prednisone	90	62
Spironolactone	Spironolactone	86	24
Fluoxetine Hcl	Fluoxetine Hcl	81	18
Atenolol	Atenolol	69	16
Amitriptyline Hcl	Amitriptyline Hcl	68	13
Mirtazapine	Mirtazapine	63	13
Tizanidine Hcl	Tizanidine Hcl	62	12
Bupropion Xl	Bupropion Hcl	60	16
Synthroid	Levothyroxine Sodium	60	13
Valsartan	Valsartan	58	14
Clopidogrel	Clopidogrel Bisulfate	54	16
Rybelsus	Semaglutide	49	12
Venlafaxine Hcl Er	Venlafaxine Hcl	47	12
Xarelto	Rivaroxaban	46	12
Citalopram Hbr	Citalopram Hydrobromide	45	13
Warfarin Sodium	Warfarin Sodium	44	16
Clonidine	Clonidine	43	suppressed
Januvia	Sitagliptin Phosphate	43	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	27
Baclofen	Baclofen	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	41	34
Ropinirole Hcl	Ropinirole Hcl	41	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Finasteride	Finasteride	38	11
Meclizine Hcl	Meclizine Hcl	38	15
Tramadol Hcl	Tramadol Hcl	38	13
Tresiba Flextouch U-200	Insulin Degludec	38	suppressed
Mounjaro	Tirzepatide	37	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	18
Fluconazole	Fluconazole	33	16
Trulicity	Dulaglutide	32	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	11
Glipizide Er	Glipizide	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	22
Irbesartan	Irbesartan	27	suppressed
Levetiracetam Er	Levetiracetam	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Mupirocin	Mupirocin	23	16
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Trospium Chloride	Trospium Chloride	23	suppressed
Cefdinir	Cefdinir	22	20
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Linzess	Linaclotide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Colestipol Hcl	Colestipol Hcl	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Nystatin	Nystatin	19	12
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Ondansetron Odt	Ondansetron	18	15
Primidone	Primidone	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Verapamil Er	Verapamil Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Azithromycin	Azithromycin	15	14
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Ramipril	Ramipril	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Naproxen	Naproxen	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error